ARVAC-A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

NCT05752201 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

2014

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Vaccine

Interventions

BIOLOGICAL: Gamma Variant RBD-based ARVAC-CG vaccine
BIOLOGICAL: Omicron Variant RBD-based ARVAC-CG vaccine
BIOLOGICAL: Bivalent RBD-based ARVAC-CG vaccine
OTHER: Placebo (Alum)

Sponsor

Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno

Collaborators

[object Object]
[object Object]
[object Object]